Back to top

oncology-screening: Archive

Zacks Equity Research

GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate

GSK enters into an exclusive licensing agreement with China-based Hansoh to develop and commercialize the latter's lung cancer candidate, HS-20093.

GSKNegative Net Change AGENNegative Net Change PBYIPositive Net Change ADMANegative Net Change